Pre-Market Stocks Recap: Accenture (NYSE:ACN), Can Fite Biopharma … – wsnewspublishers
WsnewspublishersPre-Market Stocks Recap: Accenture (NYSE:ACN), Can Fite Biopharma …wsnewspublishersIt offers CF101, which has accomplished Phase II/III clinical trials for the treatment of psoriasis; accomplished Phase II clinical trials for the treatment of rheumatoid arthritis; accomplished Phase I clinical study for the treatment of …and more »
[monetize id=”1″]
[monetize id=”2″]
1 month after shaving my head (update on my scalp …
Are We Doing Enough for our Psoriasis Patients? – ADVANCE for NPs & PAs (blog)
Are We Doing Enough for our Psoriasis Patients?ADVANCE for NPs & PAs (blog)Psoriasis is an autoimmune disease of chronic, recurrent, inflammatory plaques affecting the skin. Circumscribed, dry, scaling, erythematous plaques of various sizes characterize it with a fine white colored scale over the surface. The condition favors …and more »
